Vertex Pharmaceuticals (VRTX) Stock Analysis: AI Score & Alternative Data
VRTX alt-data: revenue climbing, job postings lagging
Is Vertex Pharmaceuticals a buy right now? The alternative data leans yes. This VRTX stock analysis is built on the 25+ alternative data signals AltIndex tracks on Vertex Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 68/100: a Buy. The stock trades at $521.12 with a $138B market cap.
What’s driving the buy signal over the past 90 days: revenue up 12.5% YoY to $3.3B, web traffic up 8.0% to 491K monthly visits, and 81% of employees are positive on the business outlook. The watch-item: job postings down 25.3% to 274 open roles.
VRTX’s broader alt-data profile also covers headcount (6K employees, according to LinkedIn), X followers (70K), and sentiment (100/100). Every signal links to its own page with full history, the VRTX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on VRTX is just below.
Vertex Pharmaceuticals AI Stock Analysis
Vertex Pharmaceuticals Inc. is a global biotechnology company headquartered in Boston, Massachusetts. Founded in 1989, the company is committed to discovering, developing, and commercializing innovative therapies aimed at treating serious diseases.
Analysis generated September 3, 2026.
Recent Vertex Pharmaceuticals Stock Alerts
|
Vertex Pharmaceuticals | September 7 David Taylor (member of U.S. congress) is selling shares |
|
Vertex Pharmaceuticals | August 18 Job postings are down by 16.4% in the last couple of days. |
|
Vertex Pharmaceuticals | August 10 Price is up by 7.5% in the last 24h. |
|
Vertex Pharmaceuticals | August 4 Employee Rating is down by 2.5% over the last month. |
Vertex Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 491K | 8.0% | |
| Job Posts | 274 | 25.3% | |
| LinkedIn Employees | 6K | 2.3% | |
| Employee Recommend | 73 | 3.9% | |
| Business Outlook | 81 | 3.6% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | 100.0% | |
| X Mentions | 3 | 93.0% | |
| Stocktwits Mentions | 14 | 16.7% | |
| News Mentions | 1 | 0% | |
| Stocktwits Subscribers | 13K | 1.0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 70K | 0% | |
| Instagram Followers | 16K | 5.3% | |
| Youtube Subscribers | 5K | 1.4% |
About Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
| Price | $521.12 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $138B |
| Year Range | $377 – $558 |
| Dividend Yield | 0% |
| PE Ratio | 31.8 |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Vertex Pharmaceuticals News
View more → |
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech StockSeptember 8 - Biztoc.com |
 |
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?September 2 - Biztoc.com |
 |
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings CallAugust 11 - Biztoc.com |
 |
Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) Earnings Call Highlights: Revenue Surges 12% to $3. ..August 3 - Biztoc.com |
 |
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call TranscriptAugust 3 - Seeking Alpha |
See Vertex Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for VRTX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEVertex Pharmaceuticals Earnings & Financial Performance
View all earnings →Vertex Pharmaceuticals Insider Trading Activity
View all →| McKechnie Duncan filed to sell 11,001 shares at $0.0. Jul 2 '26 |
| Tatsis Ourania filed to sell 45,321 shares at $0.0. Jul 2 '26 |
| Liu Joy filed to sell 19,131 shares at $0.0. Jul 1 '26 |
| Bozic Carmen filed to sell 15,933 shares at $0.0. Jun 18 '26 |
| Bozic Carmen filed to sell 21,015 shares at $0.0. Jun 5 '26 |
Vertex Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| David Taylor |
Sep 7, 26 | Sell | $8K+ |
| Alan Armstrong |
Jul 21, 26 | Buy | $8K+ |
| David Taylor |
Feb 3, 26 | Sell | $8K+ |
| David Taylor |
Sep 3, 25 | Buy | $8K+ |
| Lisa McClain |
Aug 13, 25 | Buy | $8K+ |
Stocks Similar to Vertex Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Gilead SciencesGILD |
$145.65 0.7% | $187B | 61 |
 |
RegeneronREGN |
$807.65 0.3% | $85B | 56 |
 |
Thermo Fisher ScientificTMO |
$605.69 0.4% | $227B | 66 |
 |
Revolution MedicinesRVMD |
$207.68 0.2% | $44B | 67 |
 |
IQVIAIQV |
$256.98 0.9% | $44B | 70 |
Explore Vertex Pharmaceuticals Data
Frequently Asked Questions: Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals has an AltIndex AI Score of 68/100 (Buy). The score reflects positive alternative data signals. All investments carry risk.
68/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Vertex Pharmaceuticals (VRTX) stock is $521.12 with a market cap of $138B.
As of today, Vertex Pharmaceuticals’s PE (Price to Earnings) ratio is 31.8.
View the latest Vertex Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Vertex Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The VRTX stock price chart above shows Vertex Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Vertex Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Vertex Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
